Get started
Author

Uttam Rao

ORCID: 0000-0002-2427-3076
Observed ORCID: 0000-0002-2427-3076
OpenAlex ID: A5135288397
Outcomes of lisocabtagene maraleucel (liso-cel) in patients (pt) with relapsed or refractory (R/R) mantle cell lymphoma (MCL): First real-world data from the CIBMTR.
2026 · Jennifer Jing Huang, Taylor Brooks, et al. · Journal of Clinical Oncology · 1
PDF
Hematopoietic Cell Transplant Access and Patient Diversity
2026 · Rachel Cusatis, Jianqun Kou, et al. · JAMA Network Open · 1
Phase II Study of Posttransplant Cyclophosphamide‐Based Graft‐Versus‐Host Disease Prophylaxis After HLA ‐Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort
2026 · Brian C. Shaffer, Monzr M. Al Malki, et al. · American Journal of Hematology
PDF
Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: results from the ACCESS trial
2026 · Antonio Martin Jimenez Jimenez, Joseph Stanek, et al. · Blood Advances
ORAL ABSTRACT: CT-230: Outcomes of Lisocabtagene Maraleucel (Liso-Cel) in Patients With Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): First Real-World Data From the Center for International Blood and Marrow Transplant Research (CIBMTR)
2026 · Jennifer J Huang, Taylor Brooks, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: CT-230: Outcomes of Lisocabtagene Maraleucel in Patients With Relapsed or Refractory Mantle Cell Lymphoma: First Real-World Data From the Center for International Blood and Marrow Transplant Research
2026 · Jennifer J Huang, Taylor Brooks, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-230: Outcomes of Lisocabtagene Maraleucel in Patients With Relapsed or Refractory Mantle Cell Lymphoma: First Real-World Data From the Center for International Blood and Marrow Transplant Research
2026 · Jennifer J Huang, Taylor Brooks, et al. · Clinical Lymphoma Myeloma & Leukemia
WaSMa: Workflow-Aware Scheduling for Multi-Agent LLM Systems
2026 · Uttam Rao, Ali Zafar Sadiq, et al. · Proceedings/Proceedings - International Conference on Computer Communications and Networks
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma
2026 · Nausheen Ahmed, Alaa Ali, et al. · Transplantation and Cellular Therapy
Works count: 9
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type